Surgery Partners (SGRY) Common Equity (2013 - 2026)

Surgery Partners' Common Equity history runs 14 years deep, the most recent figure standing at $3.1 billion for Q1 2026.

• In Q1 2026, Common Equity fell 1.84% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (down 1.84% YoY), while the FY2025 annual figure was $3.1 billion, down 2.04% from the prior year.
• Common Equity came in at $3.1 billion for Q1 2026 at Surgery Partners, down from $3.1 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $3.2 billion in Q4 2024 to a low of $1.7 billion in Q3 2025.
• A 5-year average of $2.8 billion and a median of $3.0 billion in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity jumped 82.09% in 2022 and tumbled 44.42% in 2025, its largest moves.
• Surgery Partners' Common Equity stood at $2.9 billion in 2022, then climbed by 3.18% to $3.0 billion in 2023, then climbed by 5.34% to $3.2 billion in 2024, then slipped by 2.04% to $3.1 billion in 2025, then fell by 1.07% to $3.1 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $3.1 billion, $3.1 billion, and $1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison